Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
December 10, 2007
- Banyu Conducts PI Study in Japan and South Korea Ahead of US
December 10, 2007
- Revised Osteoporosis GL Discussed at JOS Meeting
December 10, 2007
- Council Calls For "Extraordinary NHI Drug Price Cuts"
December 3, 2007
- Re-Pricing Runs Counter to the Promotion of Innovation: Dr Aoki
December 3, 2007
- REGULATORY NEWS IN BRIEF
December 3, 2007
- Delay in Start of PI between Japan and West Reduced to 4-6 Months: AstraZeneca
December 3, 2007
- JOINT-03 Study on Risedronate and Vitamin K2 to Start in 2008
December 3, 2007
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
December 3, 2007
- R&D NEWS IN BRIEF
December 3, 2007
- Takeda Creates New US Company for Therapeutic Antibody Research
December 3, 2007
- Kobayashi Stresses Legitimacy of Paltac-Kobashou Merger
December 3, 2007
- ASKA Aims at \10 Billion Sales with Generics
December 3, 2007
- Rohto: Strong Growth in Japan and Abroad, Annual Sales to Exceed \100 Bil.
December 3, 2007
- ZERIA: Ethical Drugs Down, Consumer Healthcare Products Up
December 3, 2007
- OPINION／Why Japanese Executives Are Grossly Underpaid
December 3, 2007
- Fuso: First Operating, Ordinary Losses Since Listing
December 3, 2007
- TOPICS／CareNet, Recruit Start Career Support Services for Doctors
December 3, 2007
- Wakamoto: Rysmon TG Shows Strong Growth
December 3, 2007
- MEDICAL DEVICE NEWS IN BRIEF
December 3, 2007
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…